Title: Abstract 18096: Interrelationship Between Reduction in Weight and Adiposity Indices and Improvement in Cardiovascular Death and Heart Failure Outcomes With Empagliflozin in Patients With Type 2 Diabetes in EMPA-REG OUTCOME
Abstract: Introduction: In EMPA-REG OUTCOME®, empagliflozin significantly reduced CV death by 38% and hospitalization for heart failure and HF death by 39%. Whether empagliflozin-mediated reduction in weight...
Publication Year: 2017
Publication Date: 2017-11-14
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot